Stockreport

GeneDx rises on Q4 beats, reiterating 2026 revenue guidance [Seeking Alpha]

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF The genetic testing provider sees revenue this year of $540M-$555M. The consensus is $542.99M. GeneDx was helped in Recommended For You More Trending News [Read more]